On Friday, May 21 (from noon until 4:00 p.m.), and Saturday, May 22 (from 9:00 a.m. until noon), Lung Cancer Initiative will host its annual Advocacy Summit for free online. At this year’s summit, you’ll hear from lung cancer researchers, physicians, advocates, caregivers and survivors, all of which will provide you with valuable information that will help you use your advocacy to advance the survivorship of lung cancer patients.
"I participate because I want to change the face of lung cancer." --2020 LCI Advocacy Summit Attendee
Our summit is open to anyone whose life has been touched by lung cancer in any capacity. Whether you’re an experienced lung cancer advocate, or looking to learn more about lung cancer in general, our advocacy summit is for you! The speakers at our summit will cover a variety of topics, such as: an introduction to lung cancer, patient navigation, biomarker testing, how to advocate through sharing your story, and what it means to think about survivorship beyond treatment. Plus, if you register by Monday, May 10 at 5:00 p.m., you will receive an Advocacy Aid Package full of LCI gifts and program materials!
Paige Humble, MBA, Executive Director, Lung Cancer Initiative: Paige Humble leads the team at Lung Cancer Initiative as Executive Director. She is a graduate of Meredith College, with a Master of Business Administration, and she received her undergraduate degree in Journalism from the University of North Carolina at Chapel Hill. Paige will give opening remarks to kick off the program.
Heidi Nafman-Onda, Founder of The White Ribbon Project: Heidi Nafman-Onda will share how use your story to raise awareness of lung cancer and make an impact on your local community. Heidi started The White Ribbon Project, which is a grassroots movement aimed and changing the public perception of lung cancer. Heidi will be the speaker for the "Survivor Advocate Story" segment.
Chris Draft, Founder, President, and CEO of the Chris Draft Family Foundation (CDFF): Chris Draft founded the CDFF, whose mission has been to empower families to lead healthy lifestyles. He is also the Co-Founder of Team Draft, leading the creation of a national campaign that is changing the face of lung cancer. He is an internationally recognized speaker, community leader, and family and character advocate who serves as an NFL Ambassador and a national spokesperson on many health-related issues, including the care and treatment of asthma, from which he suffers, and lung cancer, the disease that claimed the life of his wife, Keasha in 2011. Team Draft was founded upon a mission of action based on awareness, early detection, treatment, research, and survivorship. His twelve years as a player and established relationship with the NFL provides Team Draft with the one of the largest, visible platforms in the country. Chris will be introducing Heidi and share more about his collaboration with the White Ribbon Project nationally and internationally.
Jennifer Garst, MD, Professor of Medicine, Director of Oncology Clinical Research, Duke Cancer Center Raleigh: Dr. Jennifer Garst, MD is a medical oncology doctor who practices in Raleigh, NC at Duke Cancer Center Raleigh. She is the first Director of Oncology Clinical Research for the Duke Cancer Institute at the Duke Raleigh Cancer Center. Her mission is to provide clinical research oversight locally while collaborating with the disease-specific site-based research groups on the main campus. This integration of all oncology clinical research services includes medical oncology, surgical oncology, radiation oncology, and gynecological oncology. Dr. Garst will be presenting during the "Lung Cancer 101" segment, which will provide you with an introduction to lung cancer, updated information on screening, radon, and COVID-19 as it relates to lung cancer patients.
Messina Corder, MBA, BSN, RN, Director of Navigation, HCA North Carolina: Messina is an experienced leader with a diverse clinical and administrative background in acute and outpatient oncology services, data and accreditation, and research. She holds a Master’s Degree in Business Administration and Bachelor of Science in Nursing. Her passion for oncology care has spanned 17 years and lead to her current role as director of nurse navigation for HCA’s North Carolina division. In her free time, Messina enjoys spending time with her family, hiking, kayaking, and traveling. She will be presenting alongside Carol Logan-Thompson to share the resources available to lung cancer patients through navigation and how survivors can advocate for appropriate patient support from their providers.
Carol Logan-Thompson, RN,BSN, MSN, OCN, Thoracic Nurse Navigator, SECU Cancer Center, Mission Health: Carol Logan-Thompson, RN, BSN, MSN, OCN has worked in the field of nursing for 45 years. 44 of those years have been spent caring for oncology patients. She has worked in a variety of roles throughout her career, such as a Staff Oncology Nurse, Head Oncology Nurse, Clinical Nurse Specialist for Oncology, Assistant Professor at Western Carolina University, Radiation Oncology nurse, and most recently, a Thoracic nurse Navigator for the past 8 years. Her passion is oncology nursing, as it has been such a blessing and a rewarding experience to her. She has always received so much more from her patients and their families than she has given. When not caring for lung cancer patients, Carol enjoys spending time with her two adorable grand kids, hiking, biking, gardening and traveling.Carol will be co-leading our segment on "Lung Cancer Patient Navigation," where she will share the resources available to lung cancer patients through navigation and how survivors can advocate for appropriate patient support from their providers.
Kara Gormley Meador, Director of Media & Content Strategy, NP Strategy: Kara is an award-winning broadcast journalist, with extensive experience hosting, anchoring and reporting the news. Her expertise gleaned from years in the media positioned Kara as a choice partner to find and tell great stories in ways desirable for optimal media coverage. Whatever the outlet, Kara has the know-how to make your story a headline. Outside of her work with NP Strategy, Kara is an Adjunct Faculty member in the Honor’s College and in the School of Journalism and Mass Communications at the University of South Carolina. Kara will share tips for how to share your story with lung cancer in a way that allows you to advocate and effect change.
Day Two Speakers:
Amy Cipau, MBA, President & Founder, Lung Cancer Initiative: Amy Cipau serves as President of Lung Cancer Initiative and founded the organization along with a small group of other advocates in 2007. She continues to volunteer her time, serving as President of the Board of Directors. She received a bachelors and masters degree from East Carolina University in Industrial/Organizational Psychology and an MBA from UNC-Chapel Hill. Her previous career was in pharmaceuticals, working for Burroughs Wellcome and specializing in marketing and communications. Amy will be leading the "Welcome and Introductions" section of day two.
Chasse Bailey-Dorton, MD, MSPH, FAAFP, Chief, Section of Integrative Oncology, Assistant Professor of Medicine, Department of Supportive Oncology, Levine Cancer Institute, Atrium Health: Dr. Bailey-Dorton will be leading the segment on "Survivorship - Beyond Treatment," which will reflect on the successes and challenges of survivorship, as well as the resources available for survivorship support.
Carrie Lee, MD, MPH, Associate Professor, Medical Director, UNC Lineberger Clinical Protocol Office, UNC-Chapel Hill: Dr. Lee’s medical practice focuses on providing cutting edge treatment options and compassionate care for lung cancer patients. As the Medical Director for UNC Lineberger’s Clinical Protocol Office, Dr. Lee provides oversight for the clinical trials that investigate novel cancer therapies. Dr. Lee will share more about the new lung cancer treatment strategies that have emerged with research advances in recent years.
Aaron Eller, Account Executive, Biomarker Testing Team, Genentech: Aaron has held a number of roles centered on cancer diagnostics over the past 12 years. Currently, Aaron is a member of Genentech’s Biomarker Testing Team. His team works directly with health care professionals such as pathologists, oncologists, surgeons, navigators, payers and advocacy groups to ensure EVERY patient has the opportunity to receive and accurate and timely cancer diagnosis. Aaron will share the advances in lung cancer treatment due to biomarker testing.
Register for both days by Monday, May 10
to receive a free Advocacy Aid Package Pictured Below!